Edwards Lifesciences Corp — Director's Dealing 2014

Aug 19, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Edwards Lifesciences Corp (EW)
CIK: 0001099800
Period of Report: 2014-08-18

Reporting Person: Wood Larry L (CVP, THV Replacement)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-08-18	Common Stock	M	90000.0000	$31.4700	Acquired	103509.0237	Direct
2014-08-18	Common Stock	S	30722.0000	$97.6770	Disposed	72787.0237	Direct
2014-08-18	Common Stock	S	33030.0000	$98.0194	Disposed	39757.0237	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-08-18	Employee Stock Option (Right to Acquire)	$31.4700	M	90000.0000	Disposed	2016-05-06	Common Stock (90000.0000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	82.6669	Indirect

Footnotes

F1: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.

F2: This transaction was executed in multiple trades at prices ranging from $96.89 to $97.88. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.

F3: This transaction was executed in multiple trades at prices ranging from $97.8892 to $98.24. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.

F4: Shares represented on the most recent statement of the 401(k) Plan Administrator where a unitized accounting procedure is utilized to convert the equities to share equivalents.